Litcius/Paper detail

Improved metabolic efficacy of a dual amylin and calcitonin receptor agonist when combined with semaglutide or empagliflozin

Simone Anna Melander, Anna Katri, M.A. Karsdal, Kim Henriksen

2022European Journal of Pharmacology11 citationsDOI

Topics & Concepts

SemaglutideAmylinMedicineEmpagliflozinAgonistGlucagon-like peptide 1 receptorEndocrinologyInternal medicineType 2 diabetesPharmacologyExenatideDiabetes mellitusLiraglutideReceptorIsletDiabetes Treatment and ManagementNeuropeptides and Animal PhysiologyMetabolism, Diabetes, and Cancer
Improved metabolic efficacy of a dual amylin and calcitonin receptor agonist when combined with semaglutide or empagliflozin | Litcius